The EMBO JournalBiochemistryPeer-reviewed journal article
Prothrombinase processivity is conferred by substrate allostery
Fatma Işık ÜstokiD, Alexandre FailleiD, Alan John WarreniD, James A. HuntingtoniD
Abstract
Conversion of prothrombin to thrombin occurs in the final step of the blood coagulation cascade and depends on association of the serine protease, factor (f) Xa, and the cofactor fVa on activated cell surfaces to form the prothrombinase complex. Prothrombinase cleaves prothrombin at two sites in a processive manner [~]500,000-times faster than fXa on its own. How fVa confers rapid and processive cleavage of prothrombin is an enzymatical mystery with profound consequence. We created a variant of fXa that binds to fVa with high affinity in the absence of phospholipids that preserves the activity of wild-type prothrombinase, and recently reported on the cryo-EM structure of the complex. It revealed an extensive interface between the two proteins, including a critical interaction between the first acidic region C-terminal to the A2 domain of fVa (the N-terminal portion of the a2-loop) with the heparin binding site of fXa. Here we present the cryo-EM structures of prothrombinase bound to prothrombin and the intermediate meizothrombin, both to 3.1 [A] resolution. The prothrombin complex revealed a surprising interaction between the second acidic region of the a2-loop with exosite I of prothrombin, accounting for 70% of the total buried surface area. Cleavage at Arg320 triggers the zymogen-to-protease conformational change in meizothrombin which alters all domain-domain and fVa interactions, and results in the presentation of the second cleavage site (Arg271) for processing. Together, these structures reveal a remarkable enzymatic mechanism that depends on the active participation of the substrate itself, and introduce the new paradigm of substrate allostery.
- Citations
- 0
- FWCI
- 0.00
- Field percentile
- 25th percentile
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Engineering a membrane-independent human prothrombinase through parsimonious mutation of factor Xa
Fatma Işık Üstok, James A. Huntington·Journal of Thrombosis and HaemostasisPeer-reviewed·Nov 5, 2025
- Cryo-EM structures of apo human Factor XIa reveal catalytic-domain flexibility and exposure of the Factor IX-binding site
Alena I. Siutkina, Alexander Neuhaus, … Dmitrii V. Kalinin·bioRxiv·Aug 26, 2026
- Thrombin activation of the factor XI dimer is a multi-staged process for each subunit
A. Bar Barroeta, P. Albanese, … R. A. Scheltema·bioRxiv·Feb 11, 2023
- The plasma Factor XIII heterotetrameric complex structure: unexpected unequal pairing within a symmetric complex
Sneha Singh, Alexis Nazabal, … Arijit Biswas·BiomoleculesPeer-reviewed·Nov 21, 2019
- Investigating the structural effects of anti-thrombin anticoagulant aptamers on activation of human prothrombin
Romualdo Troisi, Alessandro Cangiano, … Filomena Sica·Molecular TherapyPeer-reviewed·Jul 24, 2026
- Evaluation of a potential redox switch in blood coagulation tenase
K. M. Cook, D. Butera, P. J. Hogg·bioRxiv·Jan 9, 2019